3-[3-(6-FLUOROPYRIDIN-3-YL)-1,2,4-OXADIAZOL-5-YL]-N-(1-ETHYL-1H-INDOL-5-YL)-PROPANAMIDE
Compound with spectra: 1 NMR
![3-[3-(6-FLUOROPYRIDIN-3-YL)-1,2,4-OXADIAZOL-5-YL]-N-(1-ETHYL-1H-INDOL-5-YL)-PROPANAMIDE](/api/compound/5VnRB7cbNE5.png?ph=true&h=300&w=458 "3-[3-(6-FLUOROPYRIDIN-3-YL)-1,2,4-OXADIAZOL-5-YL]-N-(1-ETHYL-1H-INDOL-5-YL)-PROPANAMIDE")
| SpectraBase Compound ID | 5VnRB7cbNE5 |
|---|---|
| InChI | InChI=1S/C20H18FN5O2/c1-2-26-10-9-13-11-15(4-5-16(13)26)23-18(27)7-8-19-24-20(25-28-19)14-3-6-17(21)22-12-14/h3-6,9-12H,2,7-8H2,1H3,(H,23,27) |
| InChIKey | IOSAADHXMIFMTQ-UHFFFAOYSA-N |
| Mol Weight | 379.4 g/mol |
| Molecular Formula | C20H18FN5O2 |
| Exact Mass | 379.144453 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
1,2,4-oxadiazole-5-propanamide, 3-(2-chlorophenyl)-N-(5-quinolinyl)-
N-benzoyl-5-amino-1-(phenylsulfonyl)indole
Acetamide, N-(9-methyl-9H-carbazol-3-yl)-
3-{2-[3-(p-CHLOROPHENYL)-1,2,4-OXADIAZOL-5-YL]ETHYL}-4-(alpha,alpha,alpha,alpha',alpha',alpha'-HEXAFLUORO-3,5-XYLYL)-DELTA^2-1,2,4-TRIAZOLINE-5-THIONE
4-thiazoleacetamide, 2-(3,4-dimethoxyphenyl)-N-(1H-indol-5-yl)-
3-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-6-methyl-2-quinolinol
3-(5-isopropyl-1,2,4-oxadiazol-3-yl)-6-methyl-2-quinolinol
benzenepropanamide, N-[1-methyl-2-[[(4-methyl-2-pyrimidinyl)thio]methyl]-1H-benzimidazol-5-yl]-
3-(5-ethyl-1,2,4-oxadiazol-3-yl)-6-methyl-2-quinolinol
1,2,4-oxadiazole-5-propanamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-3-(2-pyridinyl)-
| Title | Journal or Book | Year |
|---|---|---|
| Cannabinoid receptor type 2 (CB2)-selective N-aryl-oxadiazolyl-propionamides: synthesis, radiolabelling, molecular modelling and biological evaluation | Organic and Medicinal Chemistry Letters | 2012 |